NEW YORK, Oct. 2 – GeneChip-maker Affymetrix (Nasdaq: AFFX) of Santa Clara Calif., said Monday that it would acquire privately-held computational genomics company Neomorphic of Berkeley, Calif., for about $70 million in stock, based on Friday’s close.

The companies anticipate that products resulting from the acquisition will include whole-genome, high-density GeneChip arrays, new data analysis tools, and a series of Internet-accessible information products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.